DE-111 ophthalmic solution
Sponsors
Santen Pharmaceutical Co., Ltd.
Conditions
Ocular HypertensionOpen Angle GlaucomaOpen Angle Glaucoma or Ocular Hypertension
Phase 3
DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%
CompletedNCT01342081
Start: 2011-05-31Updated: 2015-06-15
DE-111 Against Timolol Ophthalmic Solution 0.5%
CompletedNCT01342094
Start: 2011-05-31Updated: 2015-07-10
DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
CompletedNCT01343082
Start: 2011-05-31Updated: 2015-06-15